Simplexa C. Auris Direct Assay Launched by Diasorin
Diasorin has launched the Simplexa C. auris Direct kit to aid in identifying Candida auris and enhance infection control.
Read MorePosted by Chris Wolski | Mar 18, 2025 | Amplification Technologies |
Diasorin has launched the Simplexa C. auris Direct kit to aid in identifying Candida auris and enhance infection control.
Read MorePosted by Chris Wolski | Mar 14, 2025 | Emerging & Zoonotic Diseases |
Amid cases of measles, H5N1, and Mpox, a weakened public health infrastructure and anti-science sentiment could result in a pandemic redux.
Read MorePosted by Chris Wolski | Mar 12, 2025 | Pancreatic |
Researchers have identified race-associated differences in pancreatic cancer, highlighting the need for diverse clinical trial participation.
Read MorePosted by Chris Wolski | Mar 7, 2025 | Company News |
Co-Diagnostics successfully won the complete dismissal of a securities class action lawsuit on March 4, 2025.
Read MorePosted by Chris Wolski | Mar 4, 2025 | Infectious Diseases |
Smartwatches can detect infections before symptoms appear. Following a watch’s advice to isolate, could reduce disease transmission.
Read More